Answers are grounded in this paper and cite their sources.
Novel CYP51 inhibitors show antifungal activity against Candida albicans, highlighting potential new treatment options.
Invasive fungal infections caused by Candida albicans are becoming increasingly severe, creating an urgent need to explore new antifungal drugs. Compound YW-01 is a structurally novel CYP51 inhibitor that was...
No takes yet. Share an insight, caveat, or question.
Gao et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: